Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Depreciation & Amortization (CF) (2020)

Journey Medical (DERM) has disclosed Depreciation & Amortization (CF) for 1 consecutive years, with $1000.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Depreciation & Amortization (CF) changed N/A year-over-year to $1000.0, compared with a TTM value of $1000.0 through Sep 2021, changed N/A, and an annual FY2020 reading of $5000.0, changed N/A over the prior year.
  • Depreciation & Amortization (CF) was $1000.0 for Q4 2020 at Journey Medical, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1000.0 in Q3 2020 and bottomed at $1000.0 in Q3 2020.